|
|
||||||||
From the Laboratory of Parasitic Diseases and Laboratory of Microbial Immunity, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014
Abstract
The cellular basis of immunity to sporozoites was investigated by examining the effect of immunization of T and B cell-deficient C57BL/6N x BALB/c AnN F1 (BLCF1) mice compared to immunocompetent controls. Immunization of T cell-deficient (ATX-BM-ATS) BLCF1 mice with x-irradiated sporozoites did not result in the generation of protective immunity. The same immunization protocols protected all immunocompetent controls. In contrast, B cell-deficient (µ-suppressed) BLCF1 mice were protected by immunization in the majority of cases. The absence of detectable serum circumsporozoite precipitins or sporozoite neutralizing activity in the µ-suppressed mice that resisted a sporozoite challenge suggests a minor role for these humoral factors in protection. These data demonstrate a preeminent role for T cells in the induction of protective immunity in BLCF1 mice against a P. berghei sporozoite infection.
This article has been cited by other articles:
![]() |
J. Vanderberg, A.-K. Mueller, K. Heiss, K. Goetz, K. Matuschewski, M. Deckert, and D. Schluter Assessment of Antibody Protection against Malaria Sporozoites Must Be Done by Mosquito Injection of Sporozoites Am. J. Pathol., October 1, 2007; 171(4): 1405 - 1406. [Full Text] [PDF] |
||||
![]() |
A.-K. Mueller, M. Deckert, K. Heiss, K. Goetz, K. Matuschewski, and D. Schluter Genetically Attenuated Plasmodium berghei Liver Stages Persist and Elicit Sterile Protection Primarily via CD8 T Cells Am. J. Pathol., July 1, 2007; 171(1): 107 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Flanagan, E. A. M. Lee, M. B. Gravenor, W. H. H. Reece, B. C. Urban, T. Doherty, K. A. Bojang, M. Pinder, A. V. S. Hill, and M. Plebanski Unique T Cell Effector Functions Elicited by Plasmodium falciparum Epitopes in Malaria-Exposed Africans Tested by Three T Cell Assays J. Immunol., October 15, 2001; 167(8): 4729 - 4737. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zheng, P. Xie, and Y. Chen Molecular Cloning and Sequencing of the Circumsporozoite Protein Gene from Plasmodium falciparum Strain FCC-1/HN and Expression of the Gene in Mycobacteria J. Clin. Microbiol., August 1, 2001; 39(8): 2911 - 2915. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Phillips Current Status of Malaria and Potential for Control Clin. Microbiol. Rev., January 1, 2001; 14(1): 208 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hoffman, D Isenbarger, G. Long, M Sedegah, A Szarfman, L Waters, M. Hollingdale, P. van der Meide, D. Finbloom, and W. Ballou Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes Science, June 2, 1989; 244(4908): 1078 - 1081. [Abstract] [PDF] |
||||
![]() |
J. Egan, J. Weber, W. Ballou, M. Hollingdale, W. Majarian, D. Gordon, W. Maloy, S. Hoffman, R. Wirtz, I Schneider, et al. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development Science, April 24, 1987; 236(4800): 453 - 456. [Abstract] [PDF] |
||||
![]() |
M. Good, W. Maloy, M. Lunde, H Margalit, J. Cornette, G. Smith, B Moss, L. Miller, and J. Berzofsky Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein Science, February 27, 1987; 235(4792): 1059 - 1062. [Abstract] [PDF] |
||||
![]() |
L. Miller, R. Howard, R Carter, M. Good, V Nussenzweig, and R. Nussenzweig Research toward malaria vaccines Science, December 12, 1986; 234(4782): 1349 - 1356. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |